2026-7-6For pharmaceutical companies that have their own downstream purification capabilities, crude gonadotropin powder offers a cost-effective entry point into fertility API production. This unrefined extract, obtained from menopausal or pregnant urine, contains a complex mixture of FSH, LH, HCG, and other urinary proteins.
The value of crude powder lies in its flexibility. Buyers can apply their own proprietary purification processes to achieve desired purity levels and FSH-to-LH ratios. This is particularly attractive for generic drug manufacturers who wish to differentiate their products while keeping raw material costs low.